Skip to main navigation
UroGen Pharma, Ltd logo
  • Who We Are
    • What We Stand For
    • Leadership
    • Advocacy/Unmet Need
    • Work With Us
    • Corporate Responsibility
  • Our Portfolio
    • RTGel® Technology
    • JELMYTO® (mitomycin) for pyelocalyceal solution
    • Partnerships
  • Pipeline
  • Media & Investors
    • Media
    • Investors
      • News Releases
      • Events
      • Financials
      • Governance
      • Stocks
      • Reports
      • Resources
  • Connect

We strive to put patients first and preserve their future possibilities

Investor Relations
  • Overview
  • News Releases
  • Events
  • Financials
  • Governance
  • Stock Info
  • Reports
  • Resources

UroGen Pharma Q3 2022 Earnings Call

Nov 10, 2022 10:00 AM EST

Participant Teleconference Registration Link: https://register.vevent.com/register/BIec9ae91eac42410aa168c941aa55f3d0
Listen to webcast
  • Print this Page
    Print Page
  • Link to Email Alerts page
    Email Alerts
  • Link to RSS page
    RSS Feeds
UroGen Pharma, Ltd logo
  • Who We Are
  • Our Portfolio
  • Pipeline
  • Media
  • Investors
  • Privacy Policy
  • Patent Notice
  • Terms of Use
  • Funding Requests
Follow Us: Linkedin opens in new window Twitter opens in new window
Connect

JELMYTO®, UroGen®, and RTGel® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

© 2024 UroGen Pharma, Ltd All rights reserved

US-UGN-00269 05/24